A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
NCT07587723
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Immune Thrombocytopenia
Sponsor
Novartis Pharmaceuticals